SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3

SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, has expanded its nanoliter liquid handling portfolio with the launch of mosquito Gen3. As the most compact and accessible model of the mosquito range, this new instrument brings next-generation sequencing (NGS) cost savings to more laboratories by lowering the barrier to advanced miniaturization technology. mosquito Gen3 will be making its debut at the Festival of Genomics in Boston, June 12-13.

Image Credit: SPT Labtech

mosquito Gen3 delivers accurate and precise multi-channel pipetting from 500 nL to 5 µL, with rapid plate-to-plate motion across three available deck positions and a small benchtop footprint. Its use of individual pre-sterilized micropipettes eliminates the risk of cross-contamination, ensuring data and research integrity. Developed in collaboration with leading scientists, mosquito software enables quick method implementation and sharing, facilitating miniaturization in novel application areas.

For laboratories requiring higher throughput and greater walkaway capacity, mosquito HV genomics offers the same accuracy and volume range, with additional two deck positions.

mosquito technology has transformed genomics workflows by significantly reducing reagent consumption and scaling down reaction volumes without compromising data quality. Unlike traditional air displacement technology, mosquito’s true positive displacement technology maintains accuracy across all liquid classes and environmental conditions. This technology has enabled miniaturization of over 40 NGS kits, including industry standards such as Illumina Nextera XT, Illumina DNA Prep, NEBNext® Ultra™ II and Takara SMART-Seq chemistries.  

“Automated liquid handling has become essential for genomics labs to meet the demands of modern research. One of the key benefits of automation is the ability to miniaturize volumes, which allows for substantial cost savings and extended reach of precious samples and reagents. By expanding our range of low-volume liquid handlers, we have lowered the cost barrier to miniaturization and now offer solutions to laboratories of all resources and needs, says Kamila Koprowska, Product Manager, mosquito genomics at SPT Labtech. 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SPT Labtech. (2024, June 12). SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3. AZoLifeSciences. Retrieved on July 22, 2024 from https://www.azolifesciences.com/news/20240612/SPT-Labtech-Brings-the-Power-of-Miniaturization-to-More-Genomics-Researchers-with-mosquitoc2ae-Gen3.aspx.

  • MLA

    SPT Labtech. "SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3". AZoLifeSciences. 22 July 2024. <https://www.azolifesciences.com/news/20240612/SPT-Labtech-Brings-the-Power-of-Miniaturization-to-More-Genomics-Researchers-with-mosquitoc2ae-Gen3.aspx>.

  • Chicago

    SPT Labtech. "SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3". AZoLifeSciences. https://www.azolifesciences.com/news/20240612/SPT-Labtech-Brings-the-Power-of-Miniaturization-to-More-Genomics-Researchers-with-mosquitoc2ae-Gen3.aspx. (accessed July 22, 2024).

  • Harvard

    SPT Labtech. 2024. SPT Labtech Brings the Power of Miniaturization to More Genomics Researchers with mosquito® Gen3. AZoLifeSciences, viewed 22 July 2024, https://www.azolifesciences.com/news/20240612/SPT-Labtech-Brings-the-Power-of-Miniaturization-to-More-Genomics-Researchers-with-mosquitoc2ae-Gen3.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.